Literature DB >> 27542881

Residual Daytime Sleepiness in Obstructive Sleep Apnea After Continuous Positive Airway Pressure Optimization: Causes and Management.

Julia L Chapman1, Yasmina Serinel2, Nathaniel S Marshall3, Ronald R Grunstein4.   

Abstract

Excessive daytime sleepiness (EDS) is common in obstructive sleep apnea (OSA), but it is also common in the general population. When sleepiness remains after continuous positive airway pressure (CPAP) treatment of OSA, comorbid conditions or permanent brain injury before CPAP therapy may be the cause of the residual sleepiness. There is currently no broad approach to treating residual EDS in patients with OSA. Individual assessment must be made of comorbid conditions and medications, and of lifestyle factors that may be contributing to the sleepiness. Modafinil and armodafinil are the only pharmacologic agents indicated for residual sleepiness in these patients.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Armodafinil; CPAP; Comorbid conditions; Excessive daytime sleepiness; Modafinil; Sleep disorders; Wakefulness promoters

Mesh:

Substances:

Year:  2016        PMID: 27542881     DOI: 10.1016/j.jsmc.2016.05.005

Source DB:  PubMed          Journal:  Sleep Med Clin        ISSN: 1556-407X


  9 in total

Review 1.  Redesigning Care for OSA.

Authors:  Lucas M Donovan; Aditi Shah; Ching Li Chai-Coetzer; Ferran Barbé; Najib T Ayas; Vishesh K Kapur
Journal:  Chest       Date:  2019-10-19       Impact factor: 9.410

2.  Residual sleepiness in veterans with post-traumatic stress disorder and obstructive sleep apnea.

Authors:  Ali A El-Solh; Hoang Bui; Yolanda Lawson; Parveen Attai
Journal:  Sleep Breath       Date:  2022-07-08       Impact factor: 2.816

3.  Brazilian Thoracic Association Consensus on Sleep-disordered Breathing.

Authors:  Ricardo Luiz de Menezes Duarte; Sonia Maria Guimarães Pereira Togeiro; Luciana de Oliveira Palombini; Fabíola Paula Galhardo Rizzatti; Simone Chaves Fagondes; Flavio José Magalhães-da-Silveira; Marília Montenegro Cabral; Pedro Rodrigues Genta; Geraldo Lorenzi-Filho; Danielle Cristina Silva Clímaco; Luciano Ferreira Drager; Vitor Martins Codeço; Carlos Alberto de Assis Viegas; Marcelo Fouad Rabahi
Journal:  J Bras Pneumol       Date:  2022-07-08       Impact factor: 2.800

4.  Effect of transoral endoscopic adenoidectomy on peripheral blood T-lymphocyte subsets in children with obstructive sleep apnea-hypopnea syndrome and its treatment strategy.

Authors:  Na Yang; Yaofeng Ji; Yin Liu
Journal:  Exp Ther Med       Date:  2017-07-28       Impact factor: 2.447

5.  Taking Care of Persistent Sleepiness in Patients with Sleep Apnea.

Authors:  Vishesh K Kapur; Lucas M Donovan
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

6.  Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects.

Authors:  Ashima S Sahni; Melissa Carlucci; Malik Malik; Bharati Prasad
Journal:  Nat Sci Sleep       Date:  2019-10-23

7.  Sleep disordered breathing from preschool to early adult age and its neurocognitive complications: A preliminary report.

Authors:  Kyriaki Astara; Dimitra Siachpazidou; George D Vavougios; Dimitrios Ragias; Konstantina Vatzia; Georgia Rapti; Emmanouil Alexopoulos; Konstantinos I Gourgoulianis; Georgia Xiromerisiou
Journal:  Sleep Sci       Date:  2021 Apr-Jun

8.  Development and Comparison of Predictive Models Based on Different Types of Influencing Factors to Select the Best One for the Prediction of OSAHS Prevalence.

Authors:  Xin Fan; Mu He; Chang Tong; Xiyi Nie; Yun Zhong; Min Lu
Journal:  Front Psychiatry       Date:  2022-07-06       Impact factor: 5.435

9.  Prevalence of sleepiness and associations with quality of life in patients with sleep apnea in an online cohort.

Authors:  Lindsey J Wanberg; Rebecca E Rottapel; Michelle L Reid; Suzanne M Bertisch; Morgan Bron; Vishesh K Kapur; Shay Bujanover; Zinta Harrington; Jessie P Bakker; Sogol Javaheri; Mark Hanson; Kathleen Figetakis; Kathy Page; Sherry Hanes; Kathleen F Villa; Susan Redline
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.